Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography

Published 2009 View Full Article

Authors

Keywords

Journal

NUCLEAR MEDICINE COMMUNICATIONS

Volume 30, Issue 7, Pages 519-524

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2009-06-02

DOI

10.1097/mnm.0b013e32832cc220

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

NUCLEAR MEDICINE COMMUNICATIONS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.